New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
08:37 EDTZMH, SYKStryker, Zimmer risk/reward remains favorable, says RW Baird
Baird believes the risk/reward for both Stryker (SYK) and Zimmer Holdings (ZMH) remains favorable citing improving EBIT margins, earnings quality, and end markets, and undemanding valuations. Both are Outperform with Stryker's price target $68 and Zimmer's at $79.
News For SYK;ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
11:25 EDTSYK, ZMHStryker, Smith & Nephew rise after reports of renewed bid
Subscribe for More Information
09:05 EDTSYKStryker weighing renewed Smith & Nephew bid, Bloomberg reports
Subscribe for More Information
08:46 EDTSYKStryker weighing renewed Smith & Nephew bid, Bloomberg reports
Subscribe for More Information
07:46 EDTSYKPfizer seen set to move on from AstraZeneca as restrictions lift, Telegraph says
Subscribe for More Information
November 21, 2014
09:27 EDTSYKRumors of Smith & Nephew bid from Stryker intensify, Daily Mail says
Shares of Smith & Nephew (SNN) rallied in U.K. trading amid "intensified" rumors that Stryker (SYK) will make a GBP 13B plus bid for its rival when its Takeover Panel restrictions are removed at month end, according to The Daily Mail's "This is Money." Reference Link
November 20, 2014
10:33 EDTZMHHigh option volume stocks
High option volume stocks: KBR LM PRGO CHRW DG ZMH LGF ZTS OSIR REGI
November 19, 2014
09:11 EDTZMHZimmer reports Synovasure PJI test earns certification
Subscribe for More Information
November 18, 2014
07:30 EDTZMHZimmer agrees with EC to extend deal review deadline by 'limited number of days'
Zimmer Holdings announced that it has agreed with the European Commission to extend the deadline for the EC's review of Zimmer's proposed acquisition of Biomet by a "limited number of days" in order to provide the EC with certain additional information. Under the previous timeline, the EC had until March 11, 2015 to make a final decision on the proposed transaction. As a result of this extension, the deadline for the EC's final decision will be extended by the limited amount of additional time that Zimmer has agreed to provide to the EC. "Deadline extensions are not uncommon in such in-depth investigations. Zimmer has been working closely with the regulatory authorities to facilitate their review of the pending transaction and is encouraged by the substantial progress that has been made to date in connection with the overall regulatory process. Zimmer continues to expect to close the transaction in the first quarter of 2015," the company said.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use